Covidien gets FDA approval for microwave ablation system

12/21/2008 | American City Business Journals

Covidien has secured 510(k) clearance from the FDA for its Evident microwave ablation system, which is designed to eliminate liver tumors in patients who are not fit to undergo surgical resection. The product enables clinicians to perform laparoscopic, percutaneous and other types of ablations in about 10 minutes, Covidien said.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA